
    
      A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety,
      Tolerability and Pharmacokinetics of NKTR-118 following single and multiple ascending oral
      dose administration in healthy young and elderly Japanese subjects, and an Open Randomized,
      Crossover Study to Investigate the Effect of Food on the Pharmacokinetics after single oral
      doses of NKTR-118 in healthy male Japanese subjects
    
  